Guardant Health (GH) FCF Margin (2017 - 2026)

Guardant Health has disclosed FCF Margin across 10 years of filings, most recently posting 23.6% for Q1 2026.

• FCF Margin for Q1 2026 came in at 23.6%, up 940.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.95% (up 1744.0% YoY), and the FY2025 annual result was 23.73%, up 1347.0% from the prior year.
• FCF Margin came in at 23.6% for Q1 2026 at Guardant Health, down from 19.28% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 17.26% in Q3 2025 to a low of 109.64% in Q3 2022.
• The 5-year median for FCF Margin is 43.6% (2023), against an average of 49.77%.
• Across the five-year window, FCF Margin slumped 4659 bps in 2022 and jumped 5359 bps in 2023, its largest moves.
• Guardant Health's FCF Margin stood at 79.4% in 2022, then surged by 45 bps to 43.6% in 2023, then increased by 5 bps to 41.32% in 2024, then surged by 53 bps to 19.28% in 2025, then dropped by 22 bps to 23.6% in 2026.
• The last three FCF Margin figures came in at 23.6% (Q1 2026), 19.28% (Q4 2025), and 17.26% (Q3 2025), per Business Quant data.